Top Markets
Coin of the day
Xcell Therapeutics, Inc. Xcell Therapeutics, Inc.

Xcell Therapeutics, Inc.

373110
Rang in aandelen #30864
Xcell Therapeutics Inc. engages in the development and production of drugs for... Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells. In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.
Aandeelprijs
$0.88234581
Marktkapitalisatie
$15.26M
Verandering (1 dag)
-4.06%
Verandering (1 jaar)
-54.67%
Land
KR
Handel Xcell Therapeutics, Inc. (373110)

Categorie

Dividendrendementgeschiedenis voor Xcell Therapeutics, Inc. (373110)
Het dividendrendement (TTM) van Xcell Therapeutics, Inc. (aandelsymbool: 373110) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Xcell Therapeutics, Inc. (373110) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten